VEGFC and myocardial infarction: Although the contribution of cardiac lymphangiogenesis to improved post-MI cardiovascular outcomes is evident (6) and supported by studies that delivered intramyocardial VEGFC (13) and by Glinton et al. (12), a recent study showed that the loss of cardiac lymphatics is not detrimental to heart function after MI (17).